SARS-CoV-2 variants and considerations of inferring causality on disease severity
- 22 June 2021
- journal article
- editorial
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 21 (11), 1472-1474
- https://doi.org/10.1016/s1473-3099(21)00338-8
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide studyCMAJ : Canadian Medical Association Journal, 2021
- Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort studyThe Lancet Infectious Diseases, 2021
- Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in EnglandScience, 2021
- Hospital load and increased COVID-19 related mortality in IsraelNature Communications, 2021
- Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 FebruaryEurosurveillance, 2021
- Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7Nature, 2021
- Assessment of Mortality and Hospital Admissions Associated with Confirmed Infection with SARS-CoV-2 Variant of Concern VOC-202012/01 (B.1.1.7) a Matched Cohort and Time-to-Event AnalysisSSRN Electronic Journal, 2021
- Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort studyBMJ, 2021
- Collider bias undermines our understanding of COVID-19 disease risk and severityNature Communications, 2020